Microport Is Weighing an IPO of Heart Valve Implant Business

Microport Scientific Corp., a Shanghai-based medical device maker, is considering a Hong Kong initial public offering for its heart valve replacement business, people with knowledge of the matter said.

The company could raise about $200 million selling shares of the unit that’s developing transcatheter aortic valve implants, said the people, who asked not to be identified because the details are private. Deliberations about a possible stock offering are at an early stage, and they may not result in an IPO of the business, said the people.